Biogen Wants MS Drug Approved Globally, CEO Says

April 15 (Bloomberg) -- George Scangos, chief executive officer of Biogen Idec Inc., talks about the drugmaker's first multiple sclerosis pill Tecfidera and the company's drug pipeline. He speaks with Betty Liu on Bloomberg Television's "In the Loop." (Source: Bloomberg)
The Electric Bus Coming to Your City
08:08 - Ryan Popple, chief executive officer at Proterra, discusses the advent of electric busses being deployed in U.S. cities as funding grows to expand the technology. He speaks on “Bloomberg Markets.” (Source: Bloomberg)
  • Mitsotakis Sees Majority of Greeks Voting for Aid Offer
  • Tsakalotos Sees ECB Trying to Make Space for Solution
  • U.S. Consumer Confidence Spikes to 101.4 in June